Earnings release
Page 1
For Immediate Release UNITED THERAPEUTICS CORPORATION REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS SILVER SPRING , MD . and RESEARCH TRIANGLE PARK , N.C. , November 3 , 2021 : United Therapeutics Corporation ( Nasdaq : UTHR ) , a public benefit corporation with a purpose to provide a brighter future for patients , today announced its financial results for the quarter ended September 30 , 2021. Total revenue in the third quarter of 2021 grew 17 % year over year to $ 444.7 million , compared to $ 380.1 million in the third quarter of 2020 . " Our momentum continues with growing patient use of our medicines , which are delivered by infusion , inhalation , and tablets , " said Martine Rothblatt , Ph.D. , Chairperson and Chief Executive Officer of United Therapeutics . “ I'm also very excited about the progress of our six phase 3 clinical trials across various forms of pulmonary hypertension and pulmonary fibrosis . " 6 " We continue to add new Tyvaso® patients following the approval in PH - ILD earlier this year , with approximately 4,000 U.S. patients on Tyvaso therapy at the end of the third quarter , " said Michael Benkowitz , President and Chief Operating Officer of United Therapeutics . " Referrals for Tyvaso remain strong , and we're well on our way toward our goal of reaching 6,000 U.S. patients on Tyvaso by the end of 2022. " THIRD QUARTER 2021 FINANCIAL RESULTS Key financial highlights include ( dollars in millions , except per share data ) : Revenues Net income Non - GAAP earnings ( ¹ ) Net income , per basic share Net income , per diluted share Non - GAAP earnings , per diluted share¹ ( 1 ) $ $ A A A A A $ $ Three Months Ended September 30 , 2020 $ 198.0 $ 2021 444.7 $ 380.1 $ 162.7 $ 171.2 $ $ 173.0 $ 3.86 3.62 $ 3.42 3.84 4.16 $ 3.88 $ A A A 64.6 ( 8.5 ) 25.0 $ ( 0.24 ) ( 0.42 ) 0.28 LA LA LA LA Dollar Change $ Percentage Change 17 % ( 5 ) % 14 % ( 6 ) % ( 11 ) % 7 % See definition of non - GAAP earnings , a non - GAAP financial measure , and a reconciliation of net income to non - GAAP earnings below .